FibroGen (FGEN) Misses Q1 EPS by 26c

FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.78), $0.26 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $16.3 million versus the consensus estimate of $34 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters
• Worthington Industries (WOR) Misses Q4 EPS by 9c